Trademark Overview
On Thursday, May 30, 2024, a trademark application was filed for AMYLO with the United States Patent and Trademark Office. The USPTO has given the AMYLO trademark a serial number of 79401325. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, June 27, 2025. This trademark is owned by BeauBrain Healthcare. The AMYLO trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Software as a medical device (SaMD), downloadable, for treating Alzheimer's disease; downloadable computer software for data processing; downloadable computer software for database management; downloadable software for processing digital images; downloadable software for processing images, graphics and text; downloadable computer software for diagnosing diseases for medical purposes; downloadable computer software for use in medical decision support systems; data processing apparatus; downloadable image files of human brains; downloadable electronic documents in the field of image processing
Providing medical advice in the field of geriatrics; medical analysis for the diagnosis and treatment of persons; health care services for treating Alzheimer's disease; remote monitoring of medical data for medical diagnosis and treatment; medical analysis services for the diagnosis of Alzheimer's disease; medical diagnostic services; mental health screening services; medical testing services relating to the diagnosis and treatment of disease; performing diagnosis of diseases; medical advisory services relating to the treatment of degenerative diseases
Medical apparatus for the diagnosis of cerebrovascular diseases; medical apparatus for the diagnosis of neurological diseases; medical apparatus and instruments for predicting, diagnosing, and treating Alzheimer's disease; apparatus for carrying-out diagnostic tests for Alzheimer's disease for medical purposes; diagnostic apparatus for diagnosing Alzheimer's disease for medical purposes; radiological diagnostic imaging apparatus, namely, Positron Emission Tomography (PET), Computed Tomography (CT), and Magnetic Resonance Imager (MRI) for medical purposes; diagnostic measuring apparatus for medical use for measuring beta-amyloid plaque; medical apparatus and instruments, namely, apparatus for medical diagnostic testing for use in the fields of clinical diagnosis of Alzheimer's disease; automatic analyzers in the nature of PET, CT, and MRI for medical diagnosis of Alzheimer's disease; electromedical diagnostic instruments for diagnosing Alzheimer's disease
Software as a service (SAAS) services featuring software for image processing; technological and scientific remote monitoring services relating to the function of medical diagnostic devices; research and development of medical apparatus and instruments in the nature of medical diagnostic testing for others; research and development of medical equipment in the nature of medical diagnostic testing; research and development of medical devices in the nature of medical diagnostic testing; providing technological support services, namely, providing technical advice related to the research and development of medical diagnostic instruments; technological and scientific monitoring services relating to the function of medical diagnostic instruments; technology consultation in the field of artificial intelligence; research and development of diagnostic apparatus in the nature of diagnosing Alzheimer's disease; computer aided diagnostic testing services
